Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 2
1994 1
1995 1
1996 4
1997 3
1998 1
1999 4
2000 3
2001 3
2002 6
2003 5
2004 5
2005 2
2006 7
2007 6
2008 5
2009 6
2010 4
2011 3
2012 2
2013 3
2014 4
2015 28
2016 2
2017 6
2018 6
2019 6
2020 2
2021 4
2022 3
2023 1
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.
Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Musette P, Joly P; French Study Group on Autoimmune Bullous Diseases. Chen DM, et al. Among authors: musette p. Br J Dermatol. 2020 May;182(5):1111-1119. doi: 10.1111/bjd.18482. Epub 2019 Nov 28. Br J Dermatol. 2020. PMID: 31487383 Free PMC article. Clinical Trial.
Sustained Remission Without Corticosteroids Among Patients With Pemphigus Who Had Rituximab as First-Line Therapy: Follow-Up of the Ritux 3 Trial.
Tedbirt B, Maho-Vaillant M, Houivet E, Mignard C, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrede-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Benichou J, Joly P, Hébert V; French Reference Center for Autoimmune Blistering Diseases MALIBUL. Tedbirt B, et al. Among authors: musette p. JAMA Dermatol. 2024 Mar 1;160(3):290-296. doi: 10.1001/jamadermatol.2023.5679. JAMA Dermatol. 2024. PMID: 38265821 Free PMC article. Clinical Trial.
First-line rituximab combined with short-term prednisone versus prednisone alone for the treatment of pemphigus (Ritux 3): a prospective, multicentre, parallel-group, open-label randomised trial.
Joly P, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Alexandre M, Ingen-Housz-Oro S, Vabres P, Delaporte E, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bedane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Vermeulin T, Benichou J, Musette P; French study group on autoimmune bullous skin diseases. Joly P, et al. Among authors: musette p. Lancet. 2017 May 20;389(10083):2031-2040. doi: 10.1016/S0140-6736(17)30070-3. Epub 2017 Mar 22. Lancet. 2017. PMID: 28342637 Clinical Trial.
New Approaches to Investigate Drug-Induced Hypersensitivity.
Ogese MO, Ahmed S, Alferivic A, Betts CJ, Dickinson A, Faulkner L, French N, Gibson A, Hirschfield GM, Kammüller M, Meng X, Martin SF, Musette P, Norris A, Pirmohamed M, Park BK, Purcell AW, Spraggs CF, Whritenour J, Naisbitt DJ. Ogese MO, et al. Among authors: musette p. Chem Res Toxicol. 2017 Jan 17;30(1):239-259. doi: 10.1021/acs.chemrestox.6b00333. Epub 2016 Nov 15. Chem Res Toxicol. 2017. PMID: 27806199 Review.
Editorial: Skin Blistering Diseases.
Has C, Amber KT, Murrell DF, Musette P, Ludwig RJ. Has C, et al. Among authors: musette p. Front Med (Lausanne). 2019 Apr 2;6:60. doi: 10.3389/fmed.2019.00060. eCollection 2019. Front Med (Lausanne). 2019. PMID: 31001533 Free PMC article. No abstract available.
Long-Term Efficacy and Safety of Rituximab in Patients With Pemphigus Foliaceus Compared With Pemphigus Vulgaris.
Tedbirt B, Houivet E, Maho-Vaillant M, Golinski ML, Calbo S, Prost-Squarcioni C, Labeille B, Picard-Dahan C, Chaby G, Richard MA, Tancrède-Bohin E, Duvert-Lehembre S, Delaporte E, Bernard P, Caux F, Alexandre M, Musette P, Ingen-Housz-Oro S, Vabres P, Quereux G, Dupuy A, Debarbieux S, Avenel-Audran M, D'Incan M, Bédane C, Bénéton N, Jullien D, Dupin N, Misery L, Machet L, Beylot-Barry M, Dereure O, Sassolas B, Cordel N, Jeudy G, Benichou J, Hébert V, Joly P. Tedbirt B, et al. Among authors: musette p. JAMA Dermatol. 2025 Apr 1;161(4):444-446. doi: 10.1001/jamadermatol.2024.6654. JAMA Dermatol. 2025. PMID: 40042819
[Imatinib-induced DRESS].
Goldman J, Duval-Modeste AB, Lambert A, Contentin N, Courville P, Musette P, Joly P. Goldman J, et al. Among authors: musette p. Ann Dermatol Venereol. 2008 May;135(5):393-6. doi: 10.1016/j.annder.2007.10.007. Epub 2008 Apr 21. Ann Dermatol Venereol. 2008. PMID: 18457727 French.
Rituximab Therapy for Mucous Membrane Pemphigoid: A Retrospective Monocentric Study With Long-Term Follow-Up in 109 Patients.
Bohelay G, Alexandre M, Le Roux-Villet C, Sitbon I, Doan S, Soued I, Shourick J, Rousset L, Mellottee B, Heller M, Lièvre N, Zumelzu C, Morin F, Grootenboer-Mignot S, Gabison E, Caux F, Prost-Squarcioni C, Musette P. Bohelay G, et al. Among authors: musette p. Front Immunol. 2022 Jun 30;13:915205. doi: 10.3389/fimmu.2022.915205. eCollection 2022. Front Immunol. 2022. PMID: 35844526 Free PMC article.
Inguinal pigmented papules.
Musette P, Descamps V, Dupuis F, Blanchet P, Marinho E, Crickx B, Belaïch S. Musette P, et al. Arch Dermatol. 1999 Feb;135(2):205, 208. doi: 10.1001/archderm.135.2.203-c. Arch Dermatol. 1999. PMID: 10052413 No abstract available.
Autoimmune Pemphigus: Latest Advances and Emerging Therapies.
Lim YL, Bohelay G, Hanakawa S, Musette P, Janela B. Lim YL, et al. Among authors: musette p. Front Mol Biosci. 2022 Feb 4;8:808536. doi: 10.3389/fmolb.2021.808536. eCollection 2021. Front Mol Biosci. 2022. PMID: 35187073 Free PMC article. Review.
129 results